KAREN GARMON: Open Payments
NPI 1467701797 · SALISBURY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,857 in 167 payments from 28 companies in 2025. Trend: 2023 $3,432 · 2024 $3,478 · 2025 $3,857
Food & beverage: $3,857
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $882 |
| Novo Nordisk Inc | 15 | $428 |
| Amgen Inc. | 21 | $428 |
| ABBVIE INC. | 19 | $406 |
| PFIZER INC. | 19 | $347 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $230 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $173 |
| Axsome Therapeutics, Inc. | 5 | $117 |
| Phathom Pharmaceuticals, Inc. | 5 | $93 |
| Viatris Specialty LLC | 3 | $78 |
Products named: FARXIGA, AIRSUPRA, Wegovy, ELIQUIS, CAPLYTA, Kerendia, EVENITY, UBRELVY.
Industry payments across NC — which companies pay providers there.
